114 related articles for article (PubMed ID: 30345496)
1. Effect of Treatment Modality on Long Term Renal Functions in Patients With Muscle Invasive Bladder Cancer.
Hamidi N; Suer E; Ozkidik M; Gokce MI; Ozturk E; Ozcan C; Turkolmez K; Beduk Y; Baltaci S
Urol J; 2019 Jun; 16(3):274-278. PubMed ID: 30345496
[TBL] [Abstract][Full Text] [Related]
2. Survival of Patients with Chronic Kidney Disease Treated with Radical Cystectomy and Risk Factors of Glomerular Filtration Rate Loss Following Radical Cystectomy: Two Systematic Reviews and Meta-analyses of Interplay Between Radical Cystectomy and Renal Function.
Sari Motlagh R; Ghoreifi A; Yanagisawa T; Kawada T; Kikic Z; Gill I; Daneshmand S; Djaladat H; Shariat SF
Eur Urol Focus; 2024 Jan; 10(1):169-181. PubMed ID: 37442723
[TBL] [Abstract][Full Text] [Related]
3. Eligibility for neoadjuvant/adjuvant cisplatin-based chemotherapy among radical cystectomy patients.
Thompson RH; Boorjian SA; Kim SP; Cheville JC; Thapa P; Tarrel R; Dronca R; Costello B; Frank I
BJU Int; 2014 May; 113(5b):E17-21. PubMed ID: 24006893
[TBL] [Abstract][Full Text] [Related]
4. Long-term renal function in patients with chronic kidney disease following radical cystectomy and orthotopic neobladder.
Ahmadi H; Reddy S; Nguyen C; Douglawi A; Ladi-Seyedian S; Roberts S; Ghoreifi A; Ghodoussipour S; Bhanvadia SK; Djaladat H; Schuckman A; Daneshmand S
BJU Int; 2022 Aug; 130(2):200-207. PubMed ID: 35044045
[TBL] [Abstract][Full Text] [Related]
5. Renal function outcome after selective bladder-preserving tetramodality therapy consisting of maximal transurethral resection, induction chemoradiotherapy and consolidative partial cystectomy in comparison with radical cystectomy for patients with muscle-invasive bladder cancer: a two-centre retrospective study.
Fujiwara M; Yokoyama M; Toide M; Fujiwara R; Tanaka H; Oguchi T; Komai Y; Yoshida S; Matsuoka Y; Numao N; Yamamoto S; Fukui I; Yonese J; Fujii Y
Jpn J Clin Oncol; 2023 Mar; 53(3):263-269. PubMed ID: 36524369
[TBL] [Abstract][Full Text] [Related]
6. Propensity Score Analysis of Radical Cystectomy Versus Bladder-Sparing Trimodal Therapy in the Setting of a Multidisciplinary Bladder Cancer Clinic.
Kulkarni GS; Hermanns T; Wei Y; Bhindi B; Satkunasivam R; Athanasopoulos P; Bostrom PJ; Kuk C; Li K; Templeton AJ; Sridhar SS; van der Kwast TH; Chung P; Bristow RG; Milosevic M; Warde P; Fleshner NE; Jewett MAS; Bashir S; Zlotta AR
J Clin Oncol; 2017 Jul; 35(20):2299-2305. PubMed ID: 28410011
[TBL] [Abstract][Full Text] [Related]
7. Feasibility of Cisplatin-Based Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer Patients With Diminished Renal Function.
Koshkin VS; Barata PC; Rybicki LA; Zahoor H; Almassi N; Redden AM; Fergany AF; Kaouk J; Haber GP; Stephenson AJ; Ornstein MC; Gilligan T; Garcia JA; Rini BI; Grivas P
Clin Genitourin Cancer; 2018 Aug; 16(4):e879-e892. PubMed ID: 29576445
[TBL] [Abstract][Full Text] [Related]
8. Significance of second transurethral resection on patient outcomes in muscle-invasive bladder cancer patients treated with bladder-preserving multimodal therapy.
Suer E; Hamidi N; Gokce MI; Gulpinar O; Turkolmez K; Beduk Y; Baltaci S
World J Urol; 2016 Jun; 34(6):847-51. PubMed ID: 26462931
[TBL] [Abstract][Full Text] [Related]
9. [Simultaneous robot-assisted laparoscopic cystectomy and laparoscopic nephrectomy: first experience on 3 patients with short-term follow-up].
Peter J; May M; Ahmed AM; Ahmed A; Gilfrich C
Aktuelle Urol; 2012 Jul; 43(4):255-61. PubMed ID: 22869496
[TBL] [Abstract][Full Text] [Related]
10. Is continent cutaneous urinary diversion a suitable alternative to orthotopic bladder substitute and ileal conduit after cystectomy?
Al Hussein Al Awamlh B; Wang LC; Nguyen DP; Rieken M; Lee RK; Lee DJ; Flynn T; Chrystal J; Shariat SF; Scherr DS
BJU Int; 2015 Nov; 116(5):805-14. PubMed ID: 25168771
[TBL] [Abstract][Full Text] [Related]
11. The effect of the time interval between diagnosis of muscle-invasive bladder cancer and radical cystectomy on staging and survival: A Netherlands Cancer Registry analysis.
Bruins HM; Aben KK; Arends TJ; van der Heijden AG; Witjes AJ
Urol Oncol; 2016 Apr; 34(4):166.e1-6. PubMed ID: 26705102
[TBL] [Abstract][Full Text] [Related]
12. Significance of preoperative butyrylcholinesterase as an independent predictor of survival in patients with muscle-invasive bladder cancer treated with radical cystectomy.
Koie T; Ohyama C; Yamamoto H; Hatakeyama S; Imai A; Yoneyama T; Hashimoto Y; Kitayam M; Hirota K
Urol Oncol; 2014 Aug; 32(6):820-5. PubMed ID: 24951323
[TBL] [Abstract][Full Text] [Related]
13. Biphasic decline in renal function after radical cystectomy with urinary diversion.
Makino K; Nakagawa T; Kanatani A; Kawai T; Taguchi S; Otsuka M; Matsumoto A; Miyazaki H; Fujimura T; Fukuhara H; Kume H; Homma Y
Int J Clin Oncol; 2017 Apr; 22(2):359-365. PubMed ID: 27747456
[TBL] [Abstract][Full Text] [Related]
14. Prognosis of patients with muscle invasive bladder cancer who are intolerable to receive any anti-cancer treatment.
Ogawa K; Shimizu Y; Uketa S; Utsunomiya N; Kanamaru S
Cancer Treat Res Commun; 2020; 24():100195. PubMed ID: 32688293
[TBL] [Abstract][Full Text] [Related]
15. Preoperative chronic kidney disease is predictive of oncological outcome of radical cystectomy for bladder cancer.
Matsumoto A; Nakagawa T; Kanatani A; Ikeda M; Kawai T; Miyakawa J; Taguchi S; Naito A; Otsuka M; Nakanishi Y; Suzuki M; Koga F; Nagase Y; Kondo Y; Okaneya T; Tanaka Y; Miyazaki H; Fujimura T; Fukuhara H; Kume H; Igawa Y; Homma Y
World J Urol; 2018 Feb; 36(2):249-256. PubMed ID: 29185045
[TBL] [Abstract][Full Text] [Related]
16. Estimated glomerular filtration rate is unreliable in detecting renal function loss during follow-up after cystectomy and urinary diversion.
Robinson R; Tait CD; Somov P; Lau MW; Sangar VK; Ramani VA; Clarke NW
Int Urol Nephrol; 2016 Apr; 48(4):511-5. PubMed ID: 26790883
[TBL] [Abstract][Full Text] [Related]
17. Comparing long-term outcomes of primary and progressive carcinoma invading bladder muscle after radical cystectomy.
Moschini M; Sharma V; Dell'oglio P; Cucchiara V; Gandaglia G; Cantiello F; Zattoni F; Pellucchi F; Briganti A; Damiano R; Montorsi F; Salonia A; Colombo R
BJU Int; 2016 Apr; 117(4):604-10. PubMed ID: 25851271
[TBL] [Abstract][Full Text] [Related]
18. Long-term renal function outcomes after radical cystectomy.
Eisenberg MS; Thompson RH; Frank I; Kim SP; Cotter KJ; Tollefson MK; Kaushik D; Thapa P; Tarrell R; Boorjian SA
J Urol; 2014 Mar; 191(3):619-25. PubMed ID: 24036234
[TBL] [Abstract][Full Text] [Related]
19. Quality of Life in Long-term Survivors of Muscle-Invasive Bladder Cancer.
Mak KS; Smith AB; Eidelman A; Clayman R; Niemierko A; Cheng JS; Matthews J; Drumm MR; Nielsen ME; Feldman AS; Lee RJ; Zietman AL; Chen RC; Shipley WU; Milowsky MI; Efstathiou JA
Int J Radiat Oncol Biol Phys; 2016 Dec; 96(5):1028-1036. PubMed ID: 27727064
[TBL] [Abstract][Full Text] [Related]
20. A systematic review and meta-analysis on the oncological long-term outcomes after trimodality therapy and radical cystectomy with or without neoadjuvant chemotherapy for muscle-invasive bladder cancer.
Fahmy O; Khairul-Asri MG; Schubert T; Renninger M; Malek R; Kübler H; Stenzl A; Gakis G
Urol Oncol; 2018 Feb; 36(2):43-53. PubMed ID: 29102254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
